Results

eNauka >  Results >  Association Between Clinically Meaningful Improvements in Patient-Reported Outcomes and Stringent Measures of Disease Activity in Patients with Psoriatic Arthritis Treated with Upadacitinib versus Placebo or Adalimumab: Results from a Phase 3 Trial
Title Association Between Clinically Meaningful Improvements in Patient-Reported Outcomes and Stringent Measures of Disease Activity in Patients with Psoriatic Arthritis Treated with Upadacitinib versus Placebo or Adalimumab: Results from a Phase 3 Trial
Authors: Gossec, Laure; Damjanov, Nemanja S; Tsuji, Shigeyoshi; Lertratanakul, Apinya; Lippe, Ralph; Patel, Jayeshkumar; Zueger, Patrick; De, Vlam Kurt
Issue Date: 2021
Publication: ARTHRITIS & RHEUMATOLOGY
ISSN: 2326-5191 Arthritis & Rheumatology Search Idenfier
Type: Conference Paper
Collation: vol. 73 str. 3986-3989
WoS-ID: 000744545207224
URI: https://enauka.gov.rs/handle/123456789/819044
Metadata source: (Preuzeto iz Nasi u WoS)
M-category: 
Mp. category will be shown later

1
WEB OF SCIENCETM

Find the DOI


Google ScholarTM

Items in eNauka are protected by copyright, with all rights reserved, unless otherwise indicated.